Cargando…
Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules
Glycoside hydrolases (GHs) are enzymes that hydrolyze glycosidic bonds, but some of them can also catalyze the synthesis of glycosides by transglycosylation. However, the yields of this reaction are generally low since the glycosides formed end up being hydrolyzed by these same enzymes. For this rea...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312355/ https://www.ncbi.nlm.nih.gov/pubmed/35883816 http://dx.doi.org/10.3390/antiox11071325 |
_version_ | 1784753824540393472 |
---|---|
author | Méndez-Líter, Juan A. Pozo-Rodríguez, Ana Madruga, Enrique Rubert, María Santana, Andrés G. de Eugenio, Laura I. Sánchez, Cristina Martínez, Ana Prieto, Alicia Martínez, María Jesús |
author_facet | Méndez-Líter, Juan A. Pozo-Rodríguez, Ana Madruga, Enrique Rubert, María Santana, Andrés G. de Eugenio, Laura I. Sánchez, Cristina Martínez, Ana Prieto, Alicia Martínez, María Jesús |
author_sort | Méndez-Líter, Juan A. |
collection | PubMed |
description | Glycoside hydrolases (GHs) are enzymes that hydrolyze glycosidic bonds, but some of them can also catalyze the synthesis of glycosides by transglycosylation. However, the yields of this reaction are generally low since the glycosides formed end up being hydrolyzed by these same enzymes. For this reason, mutagenic variants with null or drastically reduced hydrolytic activity have been developed, thus enhancing their synthetic ability. Two mutagenic variants, a glycosynthase engineered from a β-glucosidase (BGL-1-E521G) and a thioglycoligase from a β-xylosidase (BxTW1-E495A), both from the ascomycete Talaromyces amestolkiae, were used to synthesize three novel epigallocatechin gallate (EGCG) glycosides. EGCG is a phenolic compound from green tea known for its antioxidant effects and therapeutic benefits, whose glycosylation could increase its bioavailability and improve its bioactive properties. The glycosynthase BGL-1-E521G produced a β-glucoside and a β-sophoroside of EGCG, while the thioglycoligase BxTW1-E495A formed the β-xyloside of EGCG. Glycosylation occurred in the 5″ and 4″ positions of EGCG, respectively. In this work, the reaction conditions for glycosides’ production were optimized, achieving around 90% conversion of EGCG with BGL-1-E521G and 60% with BxTW1-E495A. The glycosylation of EGCG caused a slight loss of its antioxidant capacity but notably increased its solubility (between 23 and 44 times) and, in the case of glucoside, also improved its thermal stability. All three glycosides showed better antiproliferative properties on breast adenocarcinoma cell line MDA-MB-231 than EGCG, and the glucosylated and sophorylated derivatives induced higher neuroprotection, increasing the viability of SH-S5Y5 neurons exposed to okadaic acid. |
format | Online Article Text |
id | pubmed-9312355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93123552022-07-26 Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules Méndez-Líter, Juan A. Pozo-Rodríguez, Ana Madruga, Enrique Rubert, María Santana, Andrés G. de Eugenio, Laura I. Sánchez, Cristina Martínez, Ana Prieto, Alicia Martínez, María Jesús Antioxidants (Basel) Article Glycoside hydrolases (GHs) are enzymes that hydrolyze glycosidic bonds, but some of them can also catalyze the synthesis of glycosides by transglycosylation. However, the yields of this reaction are generally low since the glycosides formed end up being hydrolyzed by these same enzymes. For this reason, mutagenic variants with null or drastically reduced hydrolytic activity have been developed, thus enhancing their synthetic ability. Two mutagenic variants, a glycosynthase engineered from a β-glucosidase (BGL-1-E521G) and a thioglycoligase from a β-xylosidase (BxTW1-E495A), both from the ascomycete Talaromyces amestolkiae, were used to synthesize three novel epigallocatechin gallate (EGCG) glycosides. EGCG is a phenolic compound from green tea known for its antioxidant effects and therapeutic benefits, whose glycosylation could increase its bioavailability and improve its bioactive properties. The glycosynthase BGL-1-E521G produced a β-glucoside and a β-sophoroside of EGCG, while the thioglycoligase BxTW1-E495A formed the β-xyloside of EGCG. Glycosylation occurred in the 5″ and 4″ positions of EGCG, respectively. In this work, the reaction conditions for glycosides’ production were optimized, achieving around 90% conversion of EGCG with BGL-1-E521G and 60% with BxTW1-E495A. The glycosylation of EGCG caused a slight loss of its antioxidant capacity but notably increased its solubility (between 23 and 44 times) and, in the case of glucoside, also improved its thermal stability. All three glycosides showed better antiproliferative properties on breast adenocarcinoma cell line MDA-MB-231 than EGCG, and the glucosylated and sophorylated derivatives induced higher neuroprotection, increasing the viability of SH-S5Y5 neurons exposed to okadaic acid. MDPI 2022-07-05 /pmc/articles/PMC9312355/ /pubmed/35883816 http://dx.doi.org/10.3390/antiox11071325 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Méndez-Líter, Juan A. Pozo-Rodríguez, Ana Madruga, Enrique Rubert, María Santana, Andrés G. de Eugenio, Laura I. Sánchez, Cristina Martínez, Ana Prieto, Alicia Martínez, María Jesús Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title | Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title_full | Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title_fullStr | Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title_full_unstemmed | Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title_short | Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules |
title_sort | glycosylation of epigallocatechin gallate by engineered glycoside hydrolases from talaromyces amestolkiae: potential antiproliferative and neuroprotective effect of these molecules |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312355/ https://www.ncbi.nlm.nih.gov/pubmed/35883816 http://dx.doi.org/10.3390/antiox11071325 |
work_keys_str_mv | AT mendezliterjuana glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT pozorodriguezana glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT madrugaenrique glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT rubertmaria glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT santanaandresg glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT deeugeniolaurai glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT sanchezcristina glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT martinezana glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT prietoalicia glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules AT martinezmariajesus glycosylationofepigallocatechingallatebyengineeredglycosidehydrolasesfromtalaromycesamestolkiaepotentialantiproliferativeandneuroprotectiveeffectofthesemolecules |